Dizlin Pharmaceuticals is a pharmaceutical research company developing new treatments for Parkinson´s disease. The company’s basic research is undertaken in collaboration with the University of Gothenburg and Linköping University in Sweden. Afflicting 10 million people worldwide, Parkinson’s disease is the world’s second most common neurodegenerative disorder, with a prevalence that is increasing with an ageing populat...
Dizlin Pharmaceuticals is a pharmaceutical research company developing new treatments for Parkinson´s disease. The company’s basic research is undertaken in collaboration with the University of Gothenburg and Linköping University in Sweden. Afflicting 10 million people worldwide, Parkinson’s disease is the world’s second most common neurodegenerative disorder, with a prevalence that is increasing with an ageing population.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.